| An exoskeleton controlled by an epidural wireless brain–machine interface in a tetraplegic patient: a proof-of-concept demonstration AL Benabid, T Costecalde, A Eliseyev, G Charvet, A Verney, S Karakas, ... The Lancet Neurology 18 (12), 1112-1122, 2019 | 351 | 2019 |
| An update on treatment options for pancreatic adenocarcinoma A Lambert, L Schwarz, I Borbath, A Henry, JL Van Laethem, D Malka, ... Therapeutic advances in medical oncology 11, 1758835919875568, 2019 | 239 | 2019 |
| Current standards and new innovative approaches for treatment of pancreatic cancer T Conroy, JB Bachet, A Ayav, F Huguet, A Lambert, C Caramella, ... European Journal of Cancer 57, 10-22, 2016 | 216 | 2016 |
| Five-year outcomes of FOLFIRINOX vs gemcitabine as adjuvant therapy for pancreatic cancer: a randomized clinical trial T Conroy, F Castan, A Lopez, A Turpin, MB Abdelghani, AC Wei, E Mitry, ... JAMA oncology 8 (11), 1571-1578, 2022 | 176 | 2022 |
| Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directions A Lambert, C Gavoille, T Conroy Therapeutic advances in gastroenterology 10 (8), 631-645, 2017 | 57 | 2017 |
| Neoadjuvant treatment strategies in resectable pancreatic cancer A Lambert, L Schwarz, M Ducreux, T Conroy Cancers 13 (18), 4724, 2021 | 28 | 2021 |
| Long-Term Sheep Implantation of WIMAGINE®, a Wireless 64-Channel Electrocorticogram Recorder F Sauter-Starace, D Ratel, C Cretallaz, M Foerster, A Lambert, C Gaude, ... Frontiers in Neuroscience 13, 847, 2019 | 27 | 2019 |
| Temperature dependent Raman and X-ray diffraction studies of anhydrous milk fat A Lambert, F Bougrioua, O Abbas, M Courty, M El Marssi, V Faivre, ... Food chemistry 267, 187-195, 2018 | 26 | 2018 |
| Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ACCORD 11 randomized trial A Lambert, M Jarlier, S Gourgou Bourgade, T Conroy PLoS One 12 (9), e0183288, 2017 | 22 | 2017 |
| Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: a French comprehensive multicentre ambispective observational cohort … M Brugel, L Letrillart, C Evrard, A Thierry, D Tougeron, M El Amrani, ... European Journal of Cancer 166, 8-20, 2022 | 21 | 2022 |
| Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group. Five-year outcomes of FOLFIRINOX vs gemcitabine as adjuvant therapy for pancreatic cancer: a randomized … T Conroy, F Castan, A Lopez, A Turpin, M Ben Abdelghani, AC Wei, ... JAMA Oncol 8 (11), 1571-1578, 2022 | 20 | 2022 |
| LBA57 Unicancer PRODIGE 24/CCTG PA6 trial: updated results of a multicenter international randomized phase III trial of adjuvant mFOLFIRINOX (mFFX) versus gemcitabine (gem) in … T Conroy, P Hammel, A Turpin, C Belletier, A Wei, E Mitry, A Lopez, ... Annals of Oncology 32, S1334, 2021 | 17 | 2021 |
| Future directions in drug development in pancreatic cancer A Lambert, T Conroy, M Ducreux Seminars in Oncology 48 (1), 47-56, 2021 | 17 | 2021 |
| Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer C Franczak, A Witz, K Geoffroy, J Demange, M Rouyer, M Husson, ... PLoS One 15 (1), e0227294, 2020 | 16 | 2020 |
| Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial R Nicolle, JB Bachet, A Harlé, J Iovanna, P Hammel, V Rebours, A Turpin, ... Journal of Clinical Oncology 42 (9), 1067-1076, 2024 | 12 | 2024 |
| Adjuvant and neoadjuvant approaches in pancreatic cancer T Conroy, A Lambert, M Ducreux Current Opinion in Oncology 35 (4), 326-333, 2023 | 12 | 2023 |
| Anosmia but not Ageusia as a COVID-19-related symptom among Cancer patients—first results from the PAPESCO-19 cohort study K Zhou, A Blanc-Lapierre, V Seegers, M Boisdron-Celle, F Bigot, ... Cancers 13 (14), 3389, 2021 | 10 | 2021 |
| Comparison of Three Real-Time PCR Assays for the Detection of PIK3CA Somatic Mutations in Formalin-Fixed Paraffin Embedded Tissues of Patients with Breast … A Lambert, J Salleron, M Lion, M Rouyer, N Lozano, A Leroux, JL Merlin, ... Pathology & Oncology Research 25, 1117-1123, 2019 | 9 | 2019 |
| cfDNA for accurate determination of RAS and BRAF mutations using OncoBEAM liquid biopsy in metastatic colorectal cancer patients: Results of the real-world multicentric … A Harle, C Gavoille, O Bouche, M Ben Abdelghani, JE Plaza, A Lambert, ... Journal of Clinical Oncology 37 (15_suppl), 3542-3542, 2019 | 9 | 2019 |
| DDB2 represses epithelial-to-mesenchymal transition and sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy J Dardare, A Witz, M Betz, A Francois, M Meras, L Lamy, A Lambert, ... Frontiers in Oncology 12, 1052163, 2022 | 8 | 2022 |
